CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zhejiang Hisoar Pharmaceutical Co., Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zhejiang Hisoar Pharmaceutical Co., Ltd.
No. 100
Waisha Zhi Road, Jiaojiang District
Phone: +86 57689088166p:+86 57689088166 TAIZHOU, ZHJ  318000  China Ticker: 002099002099
Business Summary
Zhejiang Hisoar Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production and sale of active pharmaceutical ingredients (API) and pharmaceutical intermediates, dyes and dye intermediates. The Company is mainly engaged in the pharmaceutical sector and dye sector business. The pharmaceutical sector business involves the research and development, commercial production and sale of specialty API, pharmaceutical intermediates and generic drugs, and provides customized research and development and production services (contract manufacture organization (CMO)/ contract development and manufacturing organization (CDMO)) for global pharmaceutical companies. The dye sector business covers the research and development, production and sale of environmentally friendly reactive dyes, anthraquinone dyes and dye intermediates. The Company distributes its products within the domestic market and to overseas markets.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations
2819 Industrial inorganic chemicals, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board YangchaoWang 37 11/13/2019 11/13/2019
Chief Financial Officer, Deputy General Manager, Director BingYao 41 8/29/2024 11/13/2019
General Manager, Director GuoruiXu 47 11/30/2022 11/21/2014
6 additional Officers and Directors records available in full report.

Business Names
Business Name
002099
Zhejiang Hisoar Pharmaceutical Co., Ltd.

General Information
Number of Employees: 2,612 (As of 12/31/2023)
Outstanding Shares: 1,618,715,253 (As of 4/10/2025)
Shareholders: 30,453
Stock Exchange: SHE
Fax Number: +86 57689088128


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 18, 2025